Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01865045
What this trial is testing

Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients

Who this might be right for
Malignant Pleural Mesothelioma
Armando Santoro, MD 150
Early research (Phase 1)Study completedNCT02485119
What this trial is testing

Phase I Dose Escalation Study of BAY94-9343 Given by Intravenous Infusion Every 3 Weeks in Japanese Subjects With Advanced Malignancies

Who this might be right for
Neoplasms
Bayer 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT00715611
What this trial is testing

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT05730816
What this trial is testing

MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI

Who this might be right for
Mesothelioma
Brigham and Women's Hospital 130
Testing effectiveness (Phase 2)Study completedNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 20
Testing effectiveness (Phase 2)UnknownNCT01569919
What this trial is testing

A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
MalignantPleuralMesothelioma
Wales Cancer Trials Unit 26
Not applicableUnknownNCT00253409
What this trial is testing

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
Institute of Cancer Research, United Kingdom 670
Early research (Phase 1)WithdrawnNCT02639767
What this trial is testing

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Post-approval studies (Phase 4)Study completedNCT03655834
What this trial is testing

Dose Individualization of Pemetrexed - IMPROVE-III

Who this might be right for
Non Small Cell Lung CancerMesothelioma
Radboud University Medical Center 10
Testing effectiveness (Phase 2)WithdrawnNCT01353482
What this trial is testing

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University College, London
Not applicableLooking for participantsNCT01950572
What this trial is testing

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Who this might be right for
ThymomaStomach NeoplasmsPancreatic Neoplasms+3 more
National Cancer Institute (NCI) 1,000
Testing effectiveness (Phase 2)Study completedNCT05278975
What this trial is testing

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Who this might be right for
Malignant Pleural EffusionMalignant Pleural MesotheliomaMesothelioma+3 more
RS Oncology LLC 50
Early research (Phase 1)Study completedNCT00603356
What this trial is testing

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Not applicableStudy completedNCT02958683
What this trial is testing

Chest Wall Motion Analysis in Disease

Who this might be right for
MesotheliomaLung NeoplasmsSurgery+5 more
Heart of England NHS Trust 400
Not applicableStudy completedNCT00132704
What this trial is testing

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Who this might be right for
Ovarian NeoplasmsColorectal NeoplasmsMelanoma+2 more
Memorial Sloan Kettering Cancer Center 149
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Early research (Phase 1)Study completedNCT03652077
What this trial is testing

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Who this might be right for
Cervical CancerGastric CancerStomach Cancer+18 more
Incyte Corporation 40
Testing effectiveness (Phase 2)Ended earlyNCT00859495
What this trial is testing

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Columbia University 9
Next Page